Oragenics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Oragenics and other ETFs, options, and stocks.

About OGEN

Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. 

CEO
Janet Huffman
CEOJanet Huffman
Employees
3
Employees3
Headquarters
Sarasota, Florida
HeadquartersSarasota, Florida
Founded
1996
Founded1996
Employees
3
Employees3

OGEN Key Statistics

Market cap
3.92M
Market cap3.92M
Price-Earnings ratio
-0.05
Price-Earnings ratio-0.05
Dividend yield
Dividend yield
Average volume
55.10K
Average volume55.10K
High today
$0.9323
High today$0.9323
Low today
$0.8792
Low today$0.8792
Open price
$0.8975
Open price$0.8975
Volume
29.73K
Volume29.73K
52 Week high
$18.90
52 Week high$18.90
52 Week low
$0.735
52 Week low$0.735

Stock Snapshot

The current Oragenics(OGEN) stock price is $0.93, with a market capitalization of 3.92M. The stock trades at a price-to-earnings (P/E) ratio of -0.05.

On 2026-01-14, Oragenics(OGEN) stock traded between a low of $0.88 and a high of $0.93. Shares are currently priced at $0.93, which is +6.0% above the low and 0.0% below the high.

Oragenics(OGEN) shares are trading with a volume of 29.73K, against a daily average of 55.1K.

During the past year, Oragenics(OGEN) stock moved between $0.74 at its lowest and $18.90 at its peak.

During the past year, Oragenics(OGEN) stock moved between $0.74 at its lowest and $18.90 at its peak.

People also own

Based on the portfolios of people who own OGEN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .